pancreatic cancer
Conditions
Interventions
Group H:Paravertebral Injection of 0.5% ropivacaine
Group L:Paravertebral Injection of 0.25% ropivacaine
Group T:TAP+RSB
Sponsors
Department of Anesthesiology, Shanghai Changhai Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) ASA classification: I, II; 2) aged 18-70 years; 3) pancreatic surgery.
Exclusion criteria
Exclusion criteria: 1) patients with preoperative radiotherapy and chemotherapy; 2) patients who have a history of chronic pain and use analgesics before operation; 3) preoperative hormone or steroid therapy; 4) previous neuromuscular diseases; 5) previous cognitive impairment; 6) contraindications of paravertebral block (severe coagulation dysfunction, infection or local anesthetic allergy history); 7) 18.5 >= BMI >= 30kg / m2; 8) organic heart disease or serious arrhythmia; 9) emergency operation; 10) patients undergoing upper abdominal surgery again; 11) refusal to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemodynamics; | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical prognosis;Incidence of complications; | — |
Countries
China
Contacts
Public ContactXu Tao
Department of Anesthesiology, Shanghai Changhai Hospital
Outcome results
None listed